Alumier Md Acne Clarifying Cleanser

Description

Alumier MD Acne Clarifying Cleanser is a specialized acne treatment formulated with 2% salicylic acid. This product is designed to effectively address acne-related concerns. It is available in a dosage form of 177 mL (6 fl oz) and is identified by the Natural Product Number (NPN) 80064465.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The product is to be used twice daily, specifically in the morning and evening. Prior to application, the face should be moistened with lukewarm water. A small amount of the product should be pumped into the hand, followed by the addition of water. The mixture is then to be applied to the face and neck, using a circular motion to massage it in thoroughly. After application, the product must be rinsed off completely with lukewarm water, and the skin should be gently patted dry.

For new users, it is recommended to first apply the product to a small area once a day for three days to assess for any sensitivity. If no discomfort is experienced, the user may then apply a thin layer to the entire affected area. Initially, the application should be limited to once daily, with the possibility of gradually increasing to two to three times daily as needed. Should any dryness or peeling occur, it is advised to reduce the frequency of application to once a day or every other day.

Contraindications

Use is contraindicated in the following situations:

• The product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Centre is required.

• Discontinue use and consult a healthcare professional if severe skin irritation, burning, itching, hives, swelling of the eyes or mouth, blistering, or difficulty breathing occurs.

• Avoid contact with the eyes; if contact occurs, rinse thoroughly with water.

• Concurrent use with other topical acne products may increase the risk of skin irritation and dryness. It is advised to use only one topical acne product at a time to minimize these risks.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid contact with the eyes during application. In the event of accidental contact, it is imperative to rinse the eyes thoroughly with water to mitigate potential irritation.

When utilizing this product, it is important to note that the concurrent use of other topical acne treatments may increase the likelihood of skin irritation and dryness. Therefore, patients should be counseled to use only one topical acne product at a time to minimize the risk of adverse effects.

Patients should be instructed to discontinue use and seek medical advice if they experience severe irritation, burning, or itching of the skin, hives, swelling of the eyes and mouth, blistering, or difficulty breathing. In cases where symptoms are severe or if there is no noticeable improvement within 6 to 8 weeks, a consultation with a healthcare professional is recommended.

Additionally, this product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought by contacting a Poison Control Centre or seeking emergency medical help.

Side Effects

Patients using this product may experience adverse reactions, which can vary in severity. Serious adverse reactions include severe irritation, burning or itching of the skin, hives, swelling of the eyes and mouth, blistering, and difficulty breathing. In such cases, patients are advised to stop use immediately and consult a healthcare professional.

Common adverse reactions may include skin irritation and dryness, particularly if the product is used concurrently with other topical acne treatments. To minimize the risk of irritation, it is recommended that patients use only one topical acne product at a time.

Patients should also be aware that this product is for external use only. Care should be taken to avoid contact with the eyes; if contact occurs, the affected area should be rinsed thoroughly with water. If irritation persists or if there is no improvement within 6-8 weeks, patients should seek further medical advice.

Drug Interactions

The concurrent use of multiple topical acne products may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne product be used at a time. If irritation occurs, discontinuation of additional topical agents is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Alumier Md Acne Clarifying Cleanser (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, it is crucial to contact a Poison Control Centre or seek medical assistance immediately.

Geriatric Use

Elderly patients may not have specific information regarding the use of Alumier MD Acne Clarifying Cleanser, including dosage adjustments, safety concerns, or special precautions. As such, healthcare providers should exercise caution when recommending this product to geriatric patients.

Due to the absence of clinical findings or data specific to this population, it is advisable for healthcare providers to monitor elderly patients closely for any adverse reactions or changes in skin condition when using this cleanser. Individualized assessment and consideration of the patient's overall health status and skin sensitivity are recommended to ensure safe and effective use.

Pregnancy

There is no specific information regarding the use of Alumier MD Acne Clarifying Cleanser in pregnant patients. The prescribing information does not provide safety concerns, dosage modifications, or special precautions related to the use of this product during pregnancy. Therefore, healthcare professionals should exercise caution and consider the lack of data when advising women of childbearing potential. It is recommended that pregnant patients consult their healthcare provider before using this product to ensure safety for both the mother and the developing fetus.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate action is crucial. If the substance is ingested, it is imperative to contact a Poison Control Centre or seek medical assistance without delay.

Healthcare professionals should be aware that prompt intervention can significantly influence the outcome of an overdosage scenario. Symptoms may vary depending on the specific substance involved, and monitoring for any adverse effects is essential.

Management of overdosage should include supportive care and symptomatic treatment as necessary. Continuous assessment of the patient's condition is recommended to address any complications that may arise.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Serious adverse reaction events associated with the use of this product have been reported voluntarily or through surveillance programs. Reports can be submitted to Alumier Labs Inc. at 550 Cochituate Road, Suite 25, Framingham, MA 01701.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children. In the event of accidental ingestion, patients should be instructed to call a Poison Control Centre or seek medical assistance immediately.

Patients should be informed to discontinue use and consult a healthcare professional if they experience severe skin irritation, burning, or itching, as well as symptoms such as hives, swelling of the eyes and mouth, blistering, or difficulty breathing. For more severe reactions or if there is no noticeable improvement within 6 to 8 weeks, patients are encouraged to seek further medical advice.

When using this product, it is essential to avoid contact with the eyes. Should contact occur, patients should rinse their eyes thoroughly with water. Additionally, patients should be made aware that the likelihood of skin irritation and dryness increases if they use another topical acne product concurrently. Therefore, it is recommended that they use only one topical acne product at a time to minimize the risk of irritation.

Storage and Handling

The product is supplied in packaging that includes a security seal. It is imperative that the product not be used if the security seal is broken or missing, as this may compromise the integrity of the product.

For optimal storage, the product should be kept in a controlled environment, away from direct sunlight and moisture. Specific temperature ranges for storage are not provided; however, it is advisable to maintain standard room temperature conditions.

Care should be taken to handle the product gently to avoid any damage to the packaging or the product itself.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Alumier Md Acne Clarifying Cleanser, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)